Completed
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
NCT01134341
- Conditions
- Cutaneous T-Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States
- MD Anderson Cancer Center Houston, Texas, United States